查詢結果
共有 36 筆符合條件的資料
| 序號 | 篇名 | 作者 | 日期 | 期刊 |
|---|---|---|---|---|
| 1 | 針劑接續輸注案：藥品仿單警語之違反【學習式判解評析】 Successive Infusion of Parenteral Drugs: The Violation of Warning on Drug Label |
吳志正 | 2024/12 | 月旦醫事法報告 |
| 2 | 藥品供應與健保藥價調整制度之謅議【本期企劃】 Discussion on Drug Supply and Drug Price Adjustment System of Health Insurance |
余萬能 | 2024/10 | 月旦醫事法報告 |
| 3 | 由歐盟Avastin/Lucentis案談我國藥品標示外使用的若干問題【醫法新論】 EU Avastin/Lucentis Case and Several Issues on Drug Off-label Use in Taiwan |
魏杏芳 | 2024/08 | 月旦醫事法報告 |
| 4 | 適應症外使用藥品——三個藥害救濟案例給我們的提醒【本期企劃】 Perspective on Off-Label Drug Use–Lessons from Three Drug-injury Relief Cases |
簡美夷、洪佳惠、邱睦涵、黃鈺媖、陳文雯 | 2024/07 | 月旦醫事法報告 |
| 5 | 管制藥品仿單外使用爭議案：管制藥品仿單外使用與過失致死罪及販毒罪之關係【學習式判解評析】 An Issues about Off-Label-Use of Controlled Medicines: The Off-Label-Use of Controlled Drugs and Its Outsourcing in Hospitals: Medicine's Duty to Disclosure Negligence and Unlawful Sale of Controlled Drugs |
蔡蕙芳 | 2024/06 | 月旦醫事法報告 |
| 6 | 管制藥品仿單外使用爭議案：牛奶針之愛與愁 —論醫師就管制藥品於「仿單外使用」之法律效果【學習式判解評析】 An Issue about Off-Label-Use of Controlled Medicines: The Popularity and the Worry of Propofol— On the Legal Effects of Off-Label Use of Controlled Substance by Physicians |
呂寧莉 | 2024/06 | 月旦醫事法報告 |
| 7 | 由歐盟孤兒藥案件談競爭法與藥品超額定價問題【醫法新論】 EU Orphan Drug Cases and Tackling Excessive Drug Pricing by the Enforcement of Competition Law |
魏杏芳 | 2023/06 | 月旦醫事法報告 |
| 8 | 藥師調劑處方跨行政區交付藥品行為之適法性【月旦時論】 Legality of Delivering Drugs across Administrative Regions after Dispensing Prescriptions |
余萬能 | 2021/11 | 月旦醫事法報告 |
| 9 | COVID-19疫苗及藥品之緊急使用授權【醫事法學教室】 Emergency Use Authorization for Vaccines and Medicines During the COVID-19 Pandemic |
余萬能 | 2021/07 | 月旦醫事法報告 |
| 10 | 藥品智財、管制與衛生治理【月旦時論】 Intellectual Property, Drug Regulatory, and Health Governance |
鄒孟珍、蔡昀廷、劉汗曦 | 2021/05 | 月旦醫事法報告 |
